Provider
QP2-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Program effective Date: Jan 13, 2021
Documents & Forms Results
Displaying 1281 - 1290 of 3704 results
Provider
P29-21 Reimbursement Change for Licensed Professional Clinical Counselors (LPCC)
Program effective Date: May 03, 2021
Provider
P21-21 RAP Claims Required for Home Care Claims Effective July 1, 2021
Program effective Date: May 03, 2021
Provider
P26-21 Sequestration Suspension for Medicare Lines of Business Extended
Program effective Date: May 03, 2021
Provider
P32-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Musculoskeletal Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: May 03, 2021
Provider
P22-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Program effective Date: May 03, 2021
Provider
P27-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective July 5, 2021
Program effective Date: May 03, 2021
Provider
P20-21 Removal of Four Medicare Platinum Blue Prior Authorization Requirements — Effective June 1, 2021
Program effective Date: May 03, 2021